• Hypertrophic Cardiomyopathy (HCM)
  • Vaccines: 2023 Year in Review
  • Eyecare
  • Urothelial Carcinoma
  • Women's Health
  • Hemophilia
  • Heart Failure
  • Vaccines
  • Neonatal Care
  • NSCLC
  • Type II Inflammation
  • Substance Use Disorder
  • Gene Therapy
  • Lung Cancer
  • Spinal Muscular Atrophy
  • HIV
  • Post-Acute Care
  • Liver Disease
  • Pulmonary Arterial Hypertension
  • Biologics
  • Asthma
  • Atrial Fibrillation
  • Type I Diabetes
  • RSV
  • COVID-19
  • Cardiovascular Diseases
  • Breast Cancer
  • Prescription Digital Therapeutics
  • Reproductive Health
  • The Improving Patient Access Podcast
  • Blood Cancer
  • Ulcerative Colitis
  • Respiratory Conditions
  • Multiple Sclerosis
  • Digital Health
  • Population Health
  • Sleep Disorders
  • Biosimilars
  • Plaque Psoriasis
  • Leukemia and Lymphoma
  • Oncology
  • Pediatrics
  • Urology
  • Obstetrics-Gynecology & Women's Health
  • Opioids
  • Solid Tumors
  • Autoimmune Diseases
  • Dermatology
  • Diabetes
  • Mental Health

COVID-19 death toll in the U.S. passes 500,000

Article

At 5:28 p.m. EST, the Johns Hopkins Coronavirus Resource Center shows a cumulative U.S. death total of 500,071.

Disease modelers projected back in October that more than half a million people in the U.S. would die from COVID-19 by the end of February.

Their grim projections came true today. The Associated Press reported at 4:57 p.m. Eastern Time that the U.S. death toll had exceeded 500,000.

The AP said the count came from Johns Hopkins University. The university's Coronavirus Resource Center has become an oft-visited resource for U.S. and international counts of COVID-19 cases and deaths.

This screenshot was taken at 5:28 p.m.

The CDC’s count of cumulative COVID-19 deaths is at 497, 415, but it was last updated at 12:24 p.m. today.

The American Medical Association, the American Hospital Association and the American Nurses Association put out a joint statement yesterday in anticipation of today’s news: “We mourn the loss of 500,000 people in this country, a toll that has left gaping holes in the lives of those they left behind,” the statement said in part. “We also recognize the significant declines in life expectancy our country has experienced, largely as a result of the pandemic.”

The joint statement also sounded a hopeful note the COVID-19 vaccines: “We encourage everyone to get the COVID-19 vaccine when it’s your turn. Vaccines are safe, effective, prevent illness and save lives, and are key to protecting you from COVID-19 and ending the pandemic.”

According to a Johns Hopkins tally that was late updated this morning at 3 a.m., 64,177, 474 COVID-19 vaccines have been administered to people in the U.S. and 19,438,495 have been fully vaccinated, which works out to 5.94% of the population.

Related Videos
Video 4 - "Assessing the Cost-Effectiveness of Prescription Digital Therapeutics "
Video 3 - "Harnessing Prescription Drug Therapeutics as Monotherapy and Adjunct Therapy"
Video 8 - "Demographic Differences That Impact Care"
Video 7 - "Gaps in Diabetes Education and Self Efficacy"
Video 6 - "Developing Reimbursement Models for Digital Therapeutics"
Video 5 - "Cost-Effectiveness Metrics Payers Seek for Digital Therapeutics"
Video 2 - "Bridging Care Gaps with Prescription Digital Therapeutics"
Video 1 - "Overview of Prescription Digital Therapeutics and Impact on Clinical Practice"
Video 4 - "Payer Challenges in Evaluating Digital Therapeutics"
Related Content
© 2024 MJH Life Sciences

All rights reserved.